Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Our grandkids (no doubt flush with comfortable inheritances) may not ever realize that Wednesday, Oct. 17, 2018, was the day "everything changed."
That was, of course, the day recreational "adult use" sales of cannabis became legal in Canada – the world's 10th largest economy and the first G7 member to completely legalize the green stuff.
This was a historic moment and a massive profit catalyst for weed investors.
And in a way, "Green Wednesday" was the start of a high-profit journey, not the end. Because, to be clear, Canada's bold move is a key part of a growing global trend.
Soon, markets around the world, including the United States, will be opening up as the end of marijuana prohibition plays out over the next few years.
Former Speaker of the House: “Forget Canada, American Cannabis Is Where the Action Is Going to Be” – Click Here for Details
No wonder Grand View Research forecasts the global cannabis sector will be worth $146.4 billion by 2025. And Deloitte says the Canadian market alone could be worth $22.6 billion in the next several years.
Big business sees the profit potential in Canada as well.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
Hi Micheal, any more interests on the part of Coke to partner with Aurora in the near future? Thanks to my astute wife, I have held on to our Aurora and Crons shares in anticipation of higher values (profits), Best regards…..
Did we expect the large drop in cannabis stocks following the legalization in Canada? Or did they just caught up in the downswing? Do we just ride out the huge drops?